To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZNF232TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
152 supporting clones for gene ZNF232 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BQ641476 eye, normal pigmented retinal epithelium .a 1 to 933 1 to 945   tiling clone,   945/945
(100 %)
23 diff
(97.6 %id)
NM_014519.2   .a 1 to 2076 1 to 2076 exact RefSeq, AAA   2076/2076
(100 %)
0 diff
(100 %id)
FN069382 breast carcinoma .a 393 to 473 1 to 80       80/81
(98 %)
2 diff
(97.6 %id)
DA505808 brain .a 600 to 1153 2 to 554   capped   553/553
(100 %)
3 diff
(99.5 %id)
DB286717 uterus .a 601 to 1139 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DA362448 subthalamic nucleus .a 603 to 1119 2 to 516   capped   515/515
(100 %)
1 diff
(99.9 %id)
Y15067 erythroid .a 612 to 2078 1 to 1467 exact tiling clone,   1467/1473
(99 %)
1 diff
(100.0 %id)
BJ992661 hepatoblastoma .a 617 to 1045 1 to 429       429/429
(100 %)
0 diff
(100 %id)
BG471805 eye, retinoblastoma .a 618 to 1111 1 to 494       494/494
(100 %)
1 diff
(99.8 %id)
BC016039 Eye, retinoblastoma .a 619 to 2076 1 to 1458 exact available from MGC, AAA   1458/1458
(100 %)
0 diff
(100 %id)
BG530722 embryonal carcinoma, testis .a 621 to 1206 1 to 591       589/861
(68 %)
15 diff
(98.3 %id)
CN306127 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 623 to 1141 2 to 520       519/520
(99 %)
5 diff
(99.1 %id)
CN306122 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 641 to 1093 1 to 454       454/454
(100 %)
1 diff
(99.8 %id)
BP338103 Spleen .a 647 to 1226 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BE513403 Burkitt lymphoma, lymph .a 656 to 1280 1 to 625       625/684
(91 %)
1 diff
(99.9 %id)
AA091590   .a 674 to 887 1 to 208       208/208
(100 %)
18 diff
(91.4 %id)
BQ339343 nervous_normal .a 674 to 1032 9 to 375       367/375
(97 %)
6 diff
(98.4 %id)
CV028641 mixed .a 737 to 1413 1 to 676       676/679
(99 %)
2 diff
(99.8 %id)
TI_1948126844   .a 737 to 1233 126 to 623       498/1092
(45 %)
15 diff
(98.7 %id)
TI_1948126845   .a 737 to 1399 132 to 795       664/1340
(49 %)
23 diff
(98.3 %id)
TI_1948126886   .a 737 to 1392 130 to 785       656/1096
(59 %)
25 diff
(97.8 %id)
TI_1948127159   .a 737 to 1562 129 to 970       842/1209
(69 %)
49 diff
(96.0 %id)
TI_1948127205   .a 737 to 1405 130 to 803       674/1152
(58 %)
34 diff
(97.1 %id)
TI_1948127206   .a 737 to 1625 129 to 1024       896/1354
(66 %)
35 diff
(97.5 %id)
TI_1948127481   .a 737 to 1450 129 to 844       716/1130
(63 %)
37 diff
(96.8 %id)
TI_1948127482   .a 737 to 1650 127 to 1048       922/1310
(70 %)
39 diff
(97.1 %id)
TI_1948127521   .a 737 to 1286 128 to 678       551/1130
(48 %)
15 diff
(98.7 %id)
TI_1948127522   .a 737 to 1610 129 to 1015       887/1329
(66 %)
36 diff
(97.3 %id)
TI_1948127779   .a 737 to 1326 127 to 718       592/1169
(50 %)
18 diff
(98.5 %id)
TI_1948127780   .a 737 to 1649 129 to 1041       913/1326
(68 %)
32 diff
(97.6 %id)
TI_1948127821   .a 737 to 1603 125 to 984       860/1100
(78 %)
35 diff
(96.9 %id)
TI_1948127822   .a 737 to 1709 128 to 1108       981/1327
(73 %)
49 diff
(96.4 %id)
FN144168 breast carcinoma .a 779 to 857 1 to 79       79/79
(100 %)
1 diff
(98.8 %id)
TI_1948126888   .a 882 to 1989 1224 to 125       1100/1334
(82 %)
47 diff
(96.5 %id)
TI_1948127781   .a 993 to 1989 1099 to 123       977/1280
(76 %)
36 diff
(97.2 %id)
TI_1948126846   .a 1019 to 1989 1086 to 125       962/1303
(73 %)
23 diff
(98.3 %id)
TI_1948127824   .a 1054 to 1989 1051 to 130       924/1129
(81 %)
35 diff
(96.9 %id)
TI_1948127162   .a 1059 to 1989 1064 to 129       936/1158
(80 %)
38 diff
(96.8 %id)
TI_1948127483   .a 1064 to 1989 1062 to 123       938/1376
(68 %)
31 diff
(97.8 %id)
TI_1948127161   .a 1151 to 1989 964 to 125       840/1349
(62 %)
11 diff
(99.2 %id)
TI_1948127523   .a 1151 to 1989 965 to 124       842/1331
(63 %)
19 diff
(98.6 %id)
TI_1948127823   .a 1151 to 1989 967 to 126       842/1365
(61 %)
6 diff
(99.6 %id)
TI_1948127207   .a 1154 to 1988 961 to 127       835/1328
(62 %)
8 diff
(99.4 %id)
CN306125 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1229 to 1936 13 to 720       708/720
(98 %)
7 diff
(99.1 %id)
TI_1948127208   .a 1253 to 1988 864 to 130       735/1134
(64 %)
3 diff
(99.8 %id)
TI_1948126889   .a 1280 to 1989 839 to 129       711/1113
(63 %)
0 diff
(100 %id)
CA415387 Chondrosarcoma Grade II, Left Pelvis .a 1280 to 2076 809 to 19   AAA   791/794
(99 %)
7 diff
(99.2 %id)
TI_1948127484   .a 1282 to 1989 840 to 128       713/1112
(64 %)
0 diff
(100 %id)
TI_1948127782   .a 1283 to 1989 833 to 126       708/1149
(61 %)
0 diff
(100 %id)
BJ992662 hepatoblastoma .a 1673 to 2045 373 to 1       373/373
(100 %)
0 diff
(100 %id)
AK225622 Spleen .b 1 to 1403 1 to 1403 exact tiling clone, AAA   1403/1403
(100 %)
0 diff
(100 %id)
CB997496 placenta, pre-eclamptic placenta .b 4 to 777 28 to 812       785/815
(96 %)
38 diff
(95.4 %id)
CB993583 placenta, pre-eclamptic placenta .b 4 to 772 28 to 807       780/807
(96 %)
20 diff
(97.6 %id)
CB853705 Human Lung Epithelial cells, lung .b 597 to 1265 7 to 673     Submitted on the opposite strand 667/673
(99 %)
9 diff
(98.7 %id)
DA733907   .c 1 to 784 2 to 783   tiling clone, capped   782/782
(100 %)
31 diff
(96.1 %id)
CR592276 T cells (Jurkat cell line) .c 33 to 1585 1 to 1553 exact     1553/1553
(100 %)
0 diff
(100 %id)
CR620901 T cells (Jurkat cell line) Cot10-normalized .c 33 to 1591 1 to 1559 exact tiling clone,   1559/1559
(100 %)
0 diff
(100 %id)
BX447875 T cells (Jurkat cell line) .c 33 to 867 1 to 827   fully sequenced,   827/827
(100 %)
6 diff
(99.3 %id)
BX341177   .c 33 to 776 1 to 741   fully sequenced,   741/741
(100 %)
3 diff
(99.6 %id)
CX752739 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 93 to 820 1 to 718     Submitted on the opposite strand 718/821
(87 %)
15 diff
(98.2 %id)
CX753847 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 93 to 829 1 to 732     Submitted on the opposite strand 732/827
(88 %)
10 diff
(98.8 %id)
BX341176   .c 746 to 1591 845 to 1   fully sequenced,   845/845
(100 %)
1 diff
(99.9 %id)
TI_154115641   .c 828 to 1620 891 to 111   AAA   781/903
(86 %)
17 diff
(98.2 %id)
BX447874 T cells (Jurkat cell line) .c 837 to 1585 751 to 1   fully sequenced,   751/751
(100 %)
8 diff
(99.0 %id)
BE150788 head_neck .c 887 to 1157 1 to 270       270/270
(100 %)
9 diff
(96.7 %id)
BF350284 head_neck .c 887 to 1157 1 to 270       270/270
(100 %)
9 diff
(96.7 %id)
TI_149296360   .c 896 to 1623 774 to 59   AAA   716/858
(83 %)
70 diff
(91.9 %id)
BQ187614 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 905 to 1325 1 to 421   fully sequenced,   421/421
(100 %)
0 diff
(100 %id)
TI_1948127524   .c 935 to 1533 729 to 128       602/1114
(54 %)
0 diff
(100 %id)
AW963665   .c 939 to 1619 683 to 1     Submitted on the opposite strand 683/683
(100 %)
10 diff
(98.6 %id)
CA449335 Chondrosarcoma, Left Pelvis .c 963 to 1620 675 to 19   AAA   657/657
(100 %)
1 diff
(99.9 %id)
CA307374 Alveolar Macrophage, lung .c 968 to 1620 671 to 19   AAA   653/653
(100 %)
0 diff
(100 %id)
CN306124 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 973 to 1427 1 to 455       455/455
(100 %)
1 diff
(99.8 %id)
CA307358 Alveolar Macrophage, lung .c 976 to 1620 662 to 19   AAA   644/644
(100 %)
1 diff
(99.9 %id)
BF763857 colon_est .c 1004 to 1210 11 to 217       207/224
(92 %)
5 diff
(97.8 %id)
TI_1948126847   .c 1018 to 1533 642 to 126       517/1131
(45 %)
0 diff
(100 %id)
AW371502 breast .c 1040 to 1255 1 to 216       216/221
(97 %)
7 diff
(96.9 %id)
BQ028710 placenta, Placenta Choriocarcinoma .c 1040 to 1722 700 to 19   tiling clone, AAA   682/682
(100 %)
2 diff
(99.8 %id)
DB365906   .c 1069 to 1620 550 to 1       550/552
(99 %)
18 diff
(96.8 %id)
AW517298 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1091 to 1621 531 to 1       531/531
(100 %)
1 diff
(99.9 %id)
AW629085 pooled .c 1106 to 1622 522 to 6       517/522
(99 %)
0 diff
(100 %id)
AI818444 normal prostate, Prostate .c 1109 to 1624 521 to 6       516/521
(99 %)
0 diff
(100 %id)
T64395 lung .c 1128 to 1250 1 to 139   fully sequenced,   139/139
(100 %)
1 diff
(99.3 %id)
BE463786 pooled germ cell tumors .c 1132 to 1622 494 to 4       491/494
(99 %)
0 diff
(100 %id)
AW469985 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1133 to 1621 489 to 1       489/489
(100 %)
0 diff
(100 %id)
AI690915 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1134 to 1620 487 to 1       487/487
(100 %)
0 diff
(100 %id)
AI871997 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1134 to 1624 493 to 3       491/493
(99 %)
0 diff
(100 %id)
AW316915 adenocarcinoma, Pancreas .c 1147 to 1622 482 to 7       476/482
(98 %)
0 diff
(100 %id)
AA682749   .c 1176 to 1622 452 to 6       447/452
(98 %)
0 diff
(100 %id)
AA974380 pooled germ cell tumors .c 1176 to 1623 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AI089324 uterus .c 1179 to 1621 442 to 1       442/442
(100 %)
2 diff
(99.6 %id)
AI565571 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1189 to 1620 448 to 17   AAA   432/432
(100 %)
0 diff
(100 %id)
AI972606 Prostate .c 1212 to 1623 416 to 1       416/416
(100 %)
6 diff
(98.6 %id)
AI972858 Prostate .c 1212 to 1623 412 to 1       412/412
(100 %)
0 diff
(100 %id)
BF437319 Prostate .c 1214 to 1623 410 to 1       410/410
(100 %)
1 diff
(99.8 %id)
T64207 lung .c 1220 to 1592 386 to 1   fully sequenced,   386/386
(100 %)
11 diff
(97.2 %id)
AA621180 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1225 to 1303 79 to 1       79/79
(100 %)
1 diff
(98.8 %id)
AW074353 2 pooled high-grade transitional celltumors, genitourinary tract .c 1266 to 1620 381 to 27   AAA   355/355
(100 %)
6 diff
(98.4 %id)
AI473534 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1274 to 1620 357 to 11   AAA   347/347
(100 %)
2 diff
(99.5 %id)
T35456 lung .c 1275 to 1620 343 to 1     Submitted on the opposite strand 343/350
(98 %)
4 diff
(98.9 %id)
BF000304 colon, colon tumor, RER+ .c 1293 to 1620 344 to 17   AAA   328/328
(100 %)
1 diff
(99.7 %id)
BQ184519 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1295 to 1623 343 to 16   fully sequenced, AAA   328/328
(100 %)
0 diff
(100 %id)
D29561   .c 1297 to 1620 1 to 332       332/332
(100 %)
21 diff
(93.7 %id)
AI400917 Prostate .c 1305 to 1621 317 to 1       317/317
(100 %)
0 diff
(100 %id)
BU684327 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1384 to 1623 256 to 16   AAA   241/241
(100 %)
1 diff
(99.6 %id)
BE138901 adenocarcinoma, Pancreas .c 1409 to 1624 216 to 1       216/216
(100 %)
0 diff
(100 %id)
M77876   .c 1421 to 1576 156 to 1       156/156
(100 %)
0 diff
(100 %id)
AW952625   .d 1 to 493 1 to 494   tiling clone,   494/494
(100 %)
4 diff
(99.2 %id)
AK057506 testis .d 440 to 2346 1 to 1907   tiling clone, available from FLJ,   1907/1907
(100 %)
1 diff
(100.0 %id)
DB025864 testis .d 441 to 1054 2 to 615   capped   614/614
(100 %)
1 diff
(99.9 %id)
DB140678 thymus .d 629 to 1128 2 to 503   tiling clone, capped   502/502
(100 %)
3 diff
(99.5 %id)
TI_154178771   .d 642 to 1445 72 to 875       804/847
(94 %)
29 diff
(96.6 %id)
AA314608 colon .d 652 to 1079 1 to 426       426/433
(98 %)
3 diff
(99.4 %id)
TI_1948126887   .d 663 to 1637 131 to 1117       987/1299
(75 %)
6 diff
(99.6 %id)
CN306123 embryonic stem cells, DMSO-treated H9 cellline .d 1328 to 1950 1 to 623       623/623
(100 %)
1 diff
(99.9 %id)
AW631357 2 pooled high-grade transitional celltumors, genitourinary tract .d 1342 to 1853 1 to 512   fully sequenced,   512/512
(100 %)
1 diff
(99.9 %id)
DB336531 testis .d 1755 to 2346 594 to 1       594/594
(100 %)
2 diff
(99.7 %id)
AW614860 2 pooled high-grade transitional celltumors, genitourinary tract .d 1823 to 2347 528 to 4   tiling clone, fully sequenced,   525/528
(99 %)
0 diff
(100 %id)
DC406994 thymus .e 1 to 561 1 to 561   tiling clone,   561/561
(100 %)
0 diff
(100 %id)
DC365147   .e 2 to 562 1 to 561       561/561
(100 %)
1 diff
(99.9 %id)
AK297835 heart .e 3 to 1001 1 to 999 I130T     999/999
(100 %)
1 diff
(99.9 %id)
DC356582 heart .e 3 to 570 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
DC325924 caudate nucleus .e 20 to 571 1 to 552       552/552
(100 %)
0 diff
(100 %id)
BP314270 mammary gland .e 27 to 651 1 to 629       629/629
(100 %)
21 diff
(96.7 %id)
BQ071478 brain, neuroblastoma, cell line .e 35 to 945 1 to 922 exact     922/1036
(88 %)
29 diff
(97.3 %id)
DR001034 fetal brain .e 44 to 657 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BM553388 duodenal adenocarcinoma, cell line, small intestine .e 512 to 1380 23 to 902   tiling clone, AAA   880/1035
(85 %)
23 diff
(97.8 %id)
BF927508 nervous_tumor .e 1098 to 1359 1 to 264   tiling clone,   264/278
(94 %)
6 diff
(97.9 %id)
BX955483   .f 1 to 487 1 to 487   tiling clone,   487/487
(100 %)
1 diff
(99.8 %id)
DA436697 tongue, tumor tissue .f 47 to 588 47 to 589   tiling clone, capped   543/588
(92 %)
6 diff
(99.0 %id)
TI_1948127160   .f 322 to 1305 129 to 1111 A182E L183Q L184V F185Y S187H ... tiling clone,   983/1296
(75 %)
62 diff
(95.3 %id)
CV414387 uterus_tumor .f 834 to 1139 1 to 315       315/315
(100 %)
22 diff
(93.1 %id)
F16600 pectoral muscle (after mastectomy) .f 1282 to 1458 1 to 177   tiling clone,   177/177
(100 %)
2 diff
(98.9 %id)
DB166443 thyroid gland .g-u 1 to 354 2 to 355   tiling clone, to resequence, capped   354/358
(98 %)
3 diff
(99.2 %id)
BE150843 head_neck .g-u 711 to 1393 1 to 672   tiling clone,   672/674
(99 %)
38 diff
(94.4 %id)
CV421435 head_neck .g-u 711 to 1393 1 to 672       672/674
(99 %)
38 diff
(94.4 %id)
BM787035 Ascites, stomach .g-u 1128 to 1708 1 to 581   tiling clone,   581/581
(100 %)
1 diff
(99.9 %id)
BX095734 whole brain .g-u 1164 to 1688 1 to 524   tiling clone,   524/524
(100 %)
1 diff
(99.9 %id)
Z44500 brain, total brain .g-u 1164 to 1423 1 to 260       260/260
(100 %)
0 diff
(100 %id)
R18855 whole brain .g-u 1165 to 1479 1 to 317       317/320
(99 %)
6 diff
(98.2 %id)
H13005 whole brain .g-u 1165 to 1538 1 to 379       379/383
(98 %)
10 diff
(97.4 %id)
TI_154114391   .g-u 1258 to 2173 966 to 61 exact tiling clone, AAA   906/922
(98 %)
24 diff
(97.4 %id)
AI479559 Kidney .g-u 1283 to 1656 1 to 373     Submitted on the opposite strand 373/373
(100 %)
4 diff
(99.0 %id)
DB382482 thyroid gland .g-u 1604 to 2170 562 to 1 V2C V3H I4H H5R K6X ... to resequence,   562/571
(98 %)
11 diff
(98.1 %id)
H05892 whole brain .g-u 1709 to 2170 488 to 26   AAA   463/468
(98 %)
8 diff
(98.3 %id)
F03577 brain, total brain .g-u 1894 to 2170 277 to 1       277/277
(100 %)
0 diff
(100 %id)
CN275079 embryonic stem cells, DMSO-treated H9 cellline .h 1 to 423 5 to 427   tiling clone,   427/427
(100 %)
1 diff
(99.8 %id)
AK316369 esophagus, tumor tissue .h 1 to 1542 2 to 1543 exact tiling clone,   1543/1543
(100 %)
2 diff
(99.9 %id)
DB019032 esophageal, tumor tissue .h 1 to 453 2 to 454   capped   453/453
(100 %)
1 diff
(99.8 %id)
BF974012 leiomyosarcoma cell line, uterus .h 10 to 660 1 to 655       655/660
(99 %)
7 diff
(99.0 %id)
AK298190   .h 612 to 2383 1 to 1771 exact tiling clone,   1771/1771
(100 %)
6 diff
(99.7 %id)
DA610908   .h 613 to 1160 2 to 549   capped   548/548
(100 %)
4 diff
(99.3 %id)
BP244449 Kidney .h 615 to 1213 1 to 599       599/599
(100 %)
2 diff
(99.7 %id)
T87695 liver and spleen .h 650 to 981 1 to 340       340/362
(93 %)
17 diff
(95.4 %id)
CF146340 CNCAP(3)T-225 cell line, Prostate .h 873 to 1500 8 to 634 G164W     627/634
(98 %)
6 diff
(99.1 %id)
T87696 liver and spleen .h 2372 to 2477 106 to 1   tiling clone,   106/106
(100 %)
0 diff
(100 %id)
DA733669   .i 1 to 545 2 to 545   tiling clone, capped   544/544
(100 %)
9 diff
(98.4 %id)
AA315122 colon .i 217 to 582 1 to 366   tiling clone,   366/366
(100 %)
0 diff
(100 %id)
DB365632   .i 678 to 1249 567 to 1 V2C V3H I4P H5* tiling clone,   567/568
(99 %)
16 diff
(97.2 %id)
AV718209 hypothalamus .j 1 to 724 1 to 724 exact tiling clone,   724/724
(100 %)
0 diff
(100 %id)
BU538842 adenocarcinoma, cell line, breast .k 1 to 299 1 to 303   tiling clone,   303/794
(38 %)
8 diff
(99.0 %id)
BP225405   .k 24 to 604 1 to 581 exact tiling clone,   581/581
(100 %)
1 diff
(99.9 %id)
CD701569 normal nasopharynx Gene ZNF232, variant not shown         This clone was ignored    
CN306126 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells Gene ZNF232, variant not shown         Suspected internal deletion, this clone was ignored    
BG165982 hypernephroma, cell line, Kidney Gene ZNF232, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h, .i, .j, .k Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI